Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

The document reports the 19th global case of a rare skin condition in a patient from Colombia.

Isoniazid can rarely cause hair loss, which is reversible after stopping the drug.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Lower SHBG levels may increase the risk of PCOS.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Doctors often diagnose Cushing's syndrome late, which worsens symptoms; earlier detection is needed.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Skin tags in obese individuals may indicate higher cardiovascular risk.